PMID- 16514174 OWN - NLM STAT- MEDLINE DCOM- 20060403 LR - 20190608 IS - 1535-3702 (Print) IS - 1535-3699 (Linking) VI - 231 IP - 3 DP - 2006 Mar TI - Obesity-induced hypertension develops in young rats independently of the renin-angiotensin-aldosterone system. PG - 282-7 AB - A correlation exists between obesity and hypertension. In the currently available models of diet-induced obesity, the treatment of rats with a high fat (HF) diet does not begin until adulthood. Our aim was to develop and characterize a model of pre-pubescent obesity-induced hypertension. Male Sprague-Dawley rats were fed a HF diet (35% fat) for 10 weeks, beginning at age 3 weeks. Blood pressure was measured by tail-cuff, and a terminal blood sample was obtained to measure fasting blood glucose, insulin, plasma renin, aldosterone, thiobarbitutic acid reactive substances (TBARS), and free 8-isoprostanes levels. The vascular reactivity in the aorta was assessed using a myograph. Blood pressure was increased in rats fed the HF diet (HF, 161 +/- 2 mm Hg vs. control, 137 +/- 2 mm Hg, P < 0.05). Blood glucose (HF, 155 +/- 4 mg/dL vs. control, 123 +/- 5 mg/dL, P < 0.05), insulin (HF, 232 +/- 63 pM vs. control, 60 +/- 11 pM, P < 0.05), TBARS (expressed as nM of malondialdehyde [MDA]/ml [HF, 1.8 +/- 0.37 nM MDA/ml vs. control 1.05 +/- 0.09 nM MDA/ml, P < 0.05]), and free 8-isoprostanes (HF, 229 +/- 68 pg/ml vs. control, 112 +/- 9 pg/ml, P < 0.05) levels were elevated in the HF diet group. Interestingly, plasma renin and aldosterone levels were not different between the groups. The maximum vasoconstriction to phenylephrine (10(-4) M) was increased in the HF diet group (HF, 26.1 +/- 1.5 mN vs. control 22.3 +/- 1.2 mN, P < 0.05). In conclusion, pre-pubescent rats become hypertensive and have increased oxidative stress and enhanced vasoconstriction when fed a HF diet. Surprisingly, this occurs without the increase in renin or aldosterone levels seen in the adult models of diet-induced obesity. FAU - Smith, Anita D AU - Smith AD AD - Department of Physiology, Medical College of Georgia, Augusta, 30912-3000, USA. asmithgs@students.mcg.edu FAU - Brands, Michael W AU - Brands MW FAU - Wang, Mong-Heng AU - Wang MH FAU - Dorrance, Anne M AU - Dorrance AM LA - eng GR - HL077385/HL/NHLBI NIH HHS/United States GR - HL56259/HL/NHLBI NIH HHS/United States GR - HL70887/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - Switzerland TA - Exp Biol Med (Maywood) JT - Experimental biology and medicine (Maywood, N.J.) JID - 100973463 RN - 0 (Blood Glucose) RN - 0 (Dietary Fats) RN - 0 (Insulin) RN - 0 (Thiobarbituric Acid Reactive Substances) RN - 1WS297W6MV (Phenylephrine) RN - 4964P6T9RB (Aldosterone) RN - EC 3.4.23.15 (Renin) RN - N9YNS0M02X (Acetylcholine) SB - IM MH - Acetylcholine/pharmacology MH - Aging/blood MH - Aldosterone/blood MH - Animals MH - Blood Glucose MH - Cardiovascular System/drug effects/*physiopathology MH - Dietary Fats/administration & dosage MH - Disease Models, Animal MH - Heart/anatomy & histology MH - Hypertension/*etiology/*physiopathology MH - Insulin/blood MH - Intra-Abdominal Fat/pathology MH - Male MH - Obesity/*physiopathology MH - Organ Size MH - Oxidative Stress MH - Phenylephrine/pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Renin/blood MH - Renin-Angiotensin System/*physiology MH - Thiobarbituric Acid Reactive Substances/analysis MH - Vasoconstriction/drug effects EDAT- 2006/03/04 09:00 MHDA- 2006/04/04 09:00 CRDT- 2006/03/04 09:00 PHST- 2006/03/04 09:00 [pubmed] PHST- 2006/04/04 09:00 [medline] PHST- 2006/03/04 09:00 [entrez] AID - 231/3/282 [pii] AID - 10.1177/153537020623100307 [doi] PST - ppublish SO - Exp Biol Med (Maywood). 2006 Mar;231(3):282-7. doi: 10.1177/153537020623100307.